IDEAYA Biosciences IncNASDAQ:IDYA
- LAST PRICE40.5000
- TODAY'S CHANGE (%)-1.0300 (-2.4801%)
- Bid / Lots16.1700/ 2
- Ask / Lots43.0300/ 1
- Open / Previous Close40.8900 / 41.5300
- Day Range
- 52 Week Range
- Volume761,258
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IDYA |
|---|---|---|
| 09:32 ET | 18571 | 40.89 |
| 09:34 ET | 800 | 40.875 |
| 09:38 ET | 13975 | 40.855 |
| 09:39 ET | 1452 | 41.03 |
| 09:41 ET | 1100 | 41.015 |
| 09:45 ET | 553 | 41.02 |
| 09:48 ET | 3500 | 41.11 |
| 09:50 ET | 200 | 41.1 |
| 09:52 ET | 703 | 41.005 |
| 09:54 ET | 200 | 41 |
| 09:56 ET | 200 | 41.1 |
| 09:57 ET | 1860 | 41.05 |
| 09:59 ET | 100 | 41.05 |
| 10:01 ET | 900 | 41 |
| 10:06 ET | 100 | 41.035 |
| 10:08 ET | 1000 | 40.89 |
| 10:10 ET | 300 | 40.87 |
| 10:12 ET | 803 | 40.87 |
| 10:14 ET | 100 | 40.8525 |
| 10:15 ET | 622 | 40.92 |
| 10:17 ET | 843 | 40.89 |
| 10:21 ET | 1900 | 40.98 |
| 10:24 ET | 100 | 40.985 |
| 10:26 ET | 100 | 40.985 |
| 10:28 ET | 2774 | 40.93 |
| 10:30 ET | 700 | 40.925 |
| 10:32 ET | 101702 | 41.25 |
| 10:33 ET | 100 | 41.15 |
| 10:37 ET | 100 | 41.17 |
| 10:39 ET | 100 | 41.08 |
| 10:42 ET | 100 | 41.165 |
| 10:44 ET | 100 | 41.17 |
| 10:46 ET | 200 | 41.17 |
| 10:48 ET | 300 | 41.22 |
| 10:50 ET | 200 | 41.17 |
| 10:51 ET | 1237 | 41.06 |
| 10:55 ET | 100 | 41.06 |
| 11:00 ET | 100 | 40.985 |
| 11:04 ET | 4201 | 40.76 |
| 11:06 ET | 3275 | 40.85 |
| 11:08 ET | 2396 | 40.8 |
| 11:09 ET | 200 | 40.79 |
| 11:11 ET | 400 | 40.79 |
| 11:13 ET | 100 | 40.775 |
| 11:15 ET | 900 | 40.77 |
| 11:18 ET | 200 | 40.83 |
| 11:20 ET | 400 | 40.74 |
| 11:22 ET | 600 | 40.54 |
| 11:24 ET | 1381 | 40.63 |
| 11:26 ET | 200 | 40.55 |
| 11:27 ET | 145 | 40.6069 |
| 11:29 ET | 200 | 40.61 |
| 11:31 ET | 3919 | 40.86 |
| 11:33 ET | 1000 | 40.83 |
| 11:36 ET | 400 | 40.72 |
| 11:40 ET | 6532 | 40.84 |
| 11:42 ET | 400 | 40.8 |
| 11:44 ET | 100 | 40.75 |
| 11:45 ET | 700 | 40.73 |
| 11:47 ET | 832 | 40.79 |
| 11:49 ET | 200 | 40.8 |
| 11:51 ET | 2446 | 40.8 |
| 11:56 ET | 2450 | 40.84 |
| 11:58 ET | 2988 | 40.87 |
| 12:00 ET | 600 | 40.94 |
| 12:02 ET | 600 | 41 |
| 12:03 ET | 100 | 41 |
| 12:05 ET | 1300 | 40.99 |
| 12:07 ET | 1514 | 41.07 |
| 12:09 ET | 4024 | 41.085 |
| 12:12 ET | 300 | 41.04 |
| 12:18 ET | 1227 | 41.08 |
| 12:20 ET | 200 | 41.055 |
| 12:21 ET | 100 | 41.05 |
| 12:23 ET | 3200 | 40.93 |
| 12:27 ET | 398 | 40.975 |
| 12:30 ET | 2400 | 40.995 |
| 12:34 ET | 400 | 40.97 |
| 12:38 ET | 1915 | 40.98 |
| 12:41 ET | 100 | 40.89 |
| 12:43 ET | 200 | 40.85 |
| 12:45 ET | 100 | 40.77 |
| 12:48 ET | 100 | 40.75 |
| 12:50 ET | 100 | 40.75 |
| 12:52 ET | 800 | 40.65 |
| 12:56 ET | 200 | 40.73 |
| 12:57 ET | 2479 | 40.71 |
| 12:59 ET | 100 | 40.68 |
| 01:01 ET | 748 | 40.69 |
| 01:03 ET | 100 | 40.66 |
| 01:06 ET | 700 | 40.66 |
| 01:08 ET | 100 | 40.695 |
| 01:10 ET | 6100 | 40.755 |
| 01:12 ET | 9687 | 40.72 |
| 01:14 ET | 100 | 40.73 |
| 01:15 ET | 200 | 40.735 |
| 01:17 ET | 15496 | 40.93 |
| 01:21 ET | 1273 | 40.915 |
| 01:24 ET | 9550 | 40.715 |
| 01:26 ET | 2927 | 40.71 |
| 01:28 ET | 900 | 40.75 |
| 01:30 ET | 3810 | 40.7 |
| 01:32 ET | 942 | 40.65 |
| 01:33 ET | 100 | 40.65 |
| 01:35 ET | 300 | 40.62 |
| 01:37 ET | 500 | 40.525 |
| 01:39 ET | 819 | 40.565 |
| 01:44 ET | 1701 | 40.61 |
| 01:46 ET | 700 | 40.61 |
| 01:48 ET | 900 | 40.7 |
| 01:50 ET | 300 | 40.7 |
| 01:51 ET | 200 | 40.685 |
| 01:53 ET | 3000 | 40.525 |
| 01:55 ET | 900 | 40.4594 |
| 01:57 ET | 100 | 40.45 |
| 02:00 ET | 200 | 40.49 |
| 02:02 ET | 300 | 40.45 |
| 02:04 ET | 100 | 40.43 |
| 02:08 ET | 100 | 40.41 |
| 02:09 ET | 300 | 40.4 |
| 02:13 ET | 200 | 40.4 |
| 02:15 ET | 300 | 40.39 |
| 02:18 ET | 624 | 40.39 |
| 02:24 ET | 800 | 40.305 |
| 02:26 ET | 3437 | 40.3 |
| 02:27 ET | 500 | 40.31 |
| 02:31 ET | 400 | 40.32 |
| 02:33 ET | 1000 | 40.36 |
| 02:36 ET | 3692 | 40.21 |
| 02:38 ET | 1000 | 40.17 |
| 02:40 ET | 800 | 40.2 |
| 02:42 ET | 8527 | 40.35 |
| 02:44 ET | 13036 | 40.25 |
| 02:45 ET | 400 | 40.2 |
| 02:49 ET | 1115 | 40.17 |
| 02:51 ET | 600 | 40.225 |
| 02:54 ET | 600 | 40.23 |
| 02:56 ET | 1720 | 40.2501 |
| 02:58 ET | 200 | 40.275 |
| 03:00 ET | 1100 | 40.26 |
| 03:03 ET | 900 | 40.14 |
| 03:07 ET | 300 | 40.11 |
| 03:09 ET | 1300 | 40.055 |
| 03:12 ET | 3021 | 40.07 |
| 03:14 ET | 3529 | 40.19 |
| 03:16 ET | 200 | 40.24 |
| 03:18 ET | 2339 | 40.1 |
| 03:20 ET | 1008 | 40.07 |
| 03:21 ET | 900 | 40.1 |
| 03:23 ET | 1100 | 40.13 |
| 03:25 ET | 9270 | 40.305 |
| 03:27 ET | 1815 | 40.22 |
| 03:30 ET | 47987 | 40.2 |
| 03:32 ET | 141 | 40.235 |
| 03:34 ET | 1755 | 40.39 |
| 03:36 ET | 400 | 40.46 |
| 03:38 ET | 100 | 40.46 |
| 03:39 ET | 300 | 40.49 |
| 03:41 ET | 400 | 40.52 |
| 03:43 ET | 1519 | 40.47 |
| 03:45 ET | 659 | 40.48 |
| 03:48 ET | 1325 | 40.45 |
| 03:50 ET | 2632 | 40.6 |
| 03:52 ET | 2053 | 40.6 |
| 03:54 ET | 3823 | 40.53 |
| 03:56 ET | 6259 | 40.4 |
| 03:57 ET | 5866 | 40.525 |
| 03:59 ET | 174146 | 40.5 |
May 13, 2024
DJ IDEAYA Biosciences Is Maintained at Buy by Goldman Sachs, from 12:00PM ET on Monday May 13, 2024 by Dow Jones
12:00PM ET on Monday May 13, 2024 by Dow Jones
May 8, 2024
DJ IDEAYA Biosciences Price Target Maintained With a $52.00/Share by Wedbush, from 10:24AM ET on Wednesday May 08, 2024 by Dow Jones
10:24AM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
Press Release: IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 6:01AM ET on Tuesday May 07, 2024 by Dow Jones
6:01AM ET on Tuesday May 07, 2024 by Dow JonesIDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 6:00AM ET on Tuesday May 07, 2024 by Dow Jones
6:00AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event, from 6:00AM ET on Wednesday May 01, 2024 by Dow Jones
6:00AM ET on Wednesday May 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IDEAYA Biosciences Inc | 3.1B | -20.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Summit Therapeutics Inc | 3.1B | -26.8x | --- |
Xenon Pharmaceuticals Inc | 3.0B | -14.7x | --- |
Apogee Therapeutics Inc | 2.9B | -24.6x | --- |
Avidity Biosciences Inc | 2.8B | -10.0x | --- |
Company Information
IDEAYA Biosciences, Inc. is a precision medicine oncology company. The Company is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates are darovasertib (IDE196), IDE397, IDE161 and GSK101 (Pol Theta Helicase). IDE196, a small molecule protein kinase C (PKC), inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397, is its small molecule methionine adenosyltransferase 2a (MAT2A), inhibitor. IDE161, is its small molecule poly (ADP-ribose) glycohydrolase (PARG), inhibitor. IDE196 is its clinical-stage PKC inhibitor that the Company is evaluating as a synthetic lethal combination therapy. IDE397, a MAT2A inhibitor for patients with solid tumors having MTAP deletions. IDE161 is its clinical-stage, potent and selective small molecule inhibitor of PARG for patients having tumors with defined biomarkers based on genetic mutations and/or molecular signatures.
Contact Information
- Headquarters
- 7000 Shoreline Ct Ste 350SOUTH SAN FRANCISCO, CA, United States 94080-7604
- Phone
- 650-443-6209
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Terry Rosen
- President, Chief Executive Officer, Director
- Yujiro Hata
- Senior Vice President, Principal Accounting Officer, Head - Finance and Investor Relations
- Andres Briseno
- Chief Scientific Officer
- Michael White
- Chief Medical Officer
- Darrin Beaupre
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $15.5M |
Shares Outstanding | 75.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.80 |
EPS | $-2.00 |
Book Value | $9.55 |
P/E Ratio | -20.2x |
Price/Sales (TTM) | 197.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,026.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
